Treatment
Medication clinical trials
We’re tracking 7,458 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT05494086Recruiting
Laparoscopic stomach surgery for early gastric cancer
This study looks at a surgical technique (“dual-port laparoscopic distal gastrectomy”) for people with stomach adenocarcinoma at an early, specific stage. The goal is to remove the tumor with clean margins (called an “R0” result) and see how this approach works safely.
Guangzhou, GuangdongAges 18–75 - NCT05494060RecruitingPhase 2
Adjuvant chemo plus immunotherapy for ctDNA-positive stomach cancer
This trial tests whether adding an anti-cancer immune treatment and another targeted drug to standard chemotherapy after surgery can lower the chance of cancer coming back. It is for people whose blood test (ctDNA) shows leftover cancer-related DNA after surgery.
Nanjing, JiangsuAges 18–75 - NCT05495139Recruiting
Gastric bypass stent study for fatty liver disease
This small study tests whether placing a gastric bypass stent can improve nonalcoholic fatty liver disease (fatty liver not caused by heavy alcohol). You may be considered if your liver fat is high on a special MRI scan and you meet several safety and medical history rules.
ShanghaiAges 18–65 - NCT05495698Recruiting
One or multiple inhalers plus app support for COPD
This trial looks at whether using one or more inhalers, together with a smartphone app, can help people manage chronic obstructive pulmonary disease (COPD) better. You may be eligible if you have COPD, need “triple therapy” (three medicine types), and can use the app and surveys.
Rotterdam, South HollandAges 40 years+ - NCT05497115Recruiting
Care model to improve access to mental health after trauma
This trial tests a practical care plan to help people get mental health support after a traumatic injury, especially if screening suggests risk for PTSD or depression. It may help you connect faster to the right kind of treatment after your injury.
Washington, VirginiaAges 16 years+ - NCT05497518Recruiting
KidneyCARE study for adults with chronic kidney disease
This study is for adults with chronic kidney disease (CKD), including people on dialysis or with a kidney transplant. It aims to better support kidney care by allowing more community access to research.
Danville, PennsylvaniaAges 18–120 - NCT05498064Recruiting
Study of ensartinib for advanced ALK-positive lung cancer
This real-world study looks at how ensartinib works in people with advanced ALK-positive non-small cell lung cancer (NSCLC) whose disease has continued or worsened after ALK-targeted therapy. It may help doctors understand how well the treatment works and who benefits most in everyday care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05500989Recruiting
Compare early pregnancy blood-flow markers in preeclampsia
This study looks at blood-flow and artery health signs during pregnancy to better understand why preeclampsia happens. It compares women with preeclampsia to women with an uncomplicated pregnancy, and may help improve early detection and care.
MaastrichtAges 18 years+ - NCT05502913RecruitingPhase 2
Fecal transplant plus cancer immunotherapy for lung cancer
This trial studies whether giving a fecal microbiota transplant (a stool-based sample from a carefully screened donor) alongside immune checkpoint inhibitors can improve outcomes in people with lung cancer. It aims to change the gut bacteria to help the immune system work better against the cancer.
BeershebaAges 18 years+ - NCT05503849Recruiting
Pregnancy study for women early in pregnancy in Guangzhou
This study enrolls pregnant women who are early in pregnancy and plan to deliver and live in Guangzhou. It will test a “born in Guangzhou” type intervention to see if it improves pregnancy outcomes or newborn health.
GuangzhouAges 18–50 - NCT05504265RecruitingPhase 2/Phase 3
Pain control methods during minimally invasive esophagus surgery
This study compares different ways to control pain around the time of minimally invasive esophagus surgery. It may help find a method that controls pain better and improves recovery after surgery.
BeijingAges 18–75 - NCT05505669Recruiting
Blood test study to track markers in diabetes
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
Duarte, CaliforniaAges Any age - NCT05510323RecruitingPhase 3
Immunosuppressive treatment for IgA kidney disease in stage 3–4
This trial tests whether immunosuppressive therapy (medicine that calms the immune system) helps people with IgA nephropathy and moderately to severely reduced kidney function. It is intended for adults with confirmed IgA kidney disease who still have significant protein in the urine despite standard blood-pressure kidney protection treatment.
Xi'anAges 18 years+ - NCT05511623RecruitingPhase 2
Tislelizumab with chemoradiotherapy for stage IIIC2 cervical cancer
This trial tests whether adding tislelizumab to standard chemotherapy and radiation works better as first treatment for stage IIIC2 cervical cancer. It aims to improve how well the cancer responds and controls the disease.
Nanning, GuangxiAges 18–70 - NCT05514327Recruiting
Radiation plus CAR-T for relapsed lymphoma after chemo
This study tests an “ultra-fraction” radiation treatment given before CAR-T therapy to help control aggressive lymphoma that has come back or did not respond. It may help some people bridge (bridge = hold the disease stable) while they wait for CAR-T to work.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05513638Recruiting
AI imaging tool to help diagnose prostate cancer
This study tests an AI computer tool that analyzes prostate scans to help tell if someone may have prostate cancer. It may help improve how doctors interpret imaging results and decide on next steps.
NanjingAges 60–90 - NCT05513872RecruitingPhase 1/Phase 2
Help to quit smoking using nicotine replacement while not quitting yet
This early-stage study tests ways to help adults who currently smoke daily start making progress toward quitting (or changing smoking habits) over the next 6 months. You may use nicotine replacement, and the study checks safety for people who can use it.
Chicago, IllinoisAges 18 years+ - NCT05514223Recruiting
Testing sperm samples to understand lifestyle, gut, and sperm quality
This study measures “free radicals” in sperm to see how lifestyle and the microbiota (gut/community of microbes) may relate to sperm health. You may be asked to provide a semen sample as part of standard fertility testing, unless certain health factors apply.
Groningen, Provincie GroningenAges 18–55 - NCT05514288Recruiting
Endoscopic weight-loss procedures for people with excess weight
This study looks at how well an endoscopic (camera-based) weight-loss procedure helps people lose weight and whether it’s safe. It may be for people who are considering this approach, including some who previously had bariatric surgery but didn’t keep the weight off.
Los Angeles, CaliforniaAges 18–75 - NCT05517655RecruitingPhase 4
Cystic fibrosis blood/sweat check using MRI in children
This study looks at new “imaging biomarkers” (MRI measurements) in children with cystic fibrosis (CF). It mainly aims to see how MRI findings might relate to starting the recommended CF triple-combination therapy.
Kansas City, KansasAges 6–8 - NCT05518305Recruiting
Predicting recurrent stroke risk in people with artery narrowing
This study looks at blood markers and brain/artery scan results to predict who with intracranial artery narrowing is more likely to have another stroke. It may help doctors spot higher-risk people earlier and better target prevention.
Los Angeles, CaliforniaAges 30 years+ - NCT05519878Recruiting
Light plus job therapy for fatigue in genitourinary cancer
This trial tests whether light therapy and an occupational therapy fatigue program can reduce fatigue in people with certain urinary-system cancers who still have mild fatigue during treatment. It may help you feel more energized and manage day-to-day activity while cancer treatment is ongoing.
Duarte, CaliforniaAges 18 years+ - NCT05520762Recruiting
Trial for patients after in-hospital cardiac arrest needing breathing support
This trial studies a hospital treatment for people who have a cardiac arrest while in the hospital and still need help breathing. It may help improve care right after this emergency by testing an airway resuscitation approach.
New York, New YorkAges 18 years+ - NCT05522465RecruitingPhase 4
Steroid treatment for children with ITP to raise platelets
This trial studies a short, high-dose steroid plan (prednisone plus dexamethasone) to treat immune thrombocytopenia (ITP) in children and raise low platelet counts. It may help reduce bleeding risk while using an approach tested in children soon after diagnosis.
Fujian, FujianAges 4 weeks–14 years
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,458 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.